Atypical Injectable Antipsychotics for Schizophrenia or Bipolar Disorder: A Review of Clinical Effectiveness and Cost-Effectiveness

Related Articles

Atypical Injectable Antipsychotics for Schizophrenia or Bipolar Disorder: A Review of Clinical Effectiveness and Cost-Effectiveness

Book. 2019 01 03

Authors: Narain T, Ford C

Abstract
The purpose of this report is to evaluate the clinical effectiveness and cost-effectiveness, for the use of atypical injectable antipsychotics for patients with schizophrenia or bipolar disorder.


PMID: 31095354